↓ Skip to main content

Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs

Overview of attention for article published in Frontiers in oncology, November 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
3 X users

Readers on

mendeley
106 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs
Published in
Frontiers in oncology, November 2015
DOI 10.3389/fonc.2015.00239
Pubmed ID
Authors

Surbhi Grover, Mmakgomo Raesima, Memory Bvochora-Nsingo, Sebathu P. Chiyapo, Dawn Balang, Neo Tapela, Onyinye Balogun, Mukendi K. A. Kayembe, Anthony H. Russell, Barati Monare, Senate Tanyala, Jailakshmi Bhat, Kealeboga Thipe, Metlha Nchunga, Susan Mayisela, Balladiah Kizito, Ari Ho-Foster, Babe Eunice Gaolebale, Ponatshego A. Gaolebale, Jason A. Efstathiou, Scott Dryden-Peterson, Nicola Zetola, Stephen M. Hahn, Erle S. Robertson, Lilie L. Lin, Chelsea Morroni, Doreen Ramogola-Masire

Abstract

Botswana has a high burden of cervical cancer due to a limited screening program and high HIV prevalence. About 60% of the cervical cancer patients are HIV positive; most present with advanced cervical disease. Through initiatives by the Botswana Ministry of Health and various strategic partnerships, strides have been made in treatment of pre-invasive and invasive cancer. The See and Treat program for cervical cancer is expanding throughout the country. Starting in 2015, school-going girls will be vaccinated against HPV. In regards to treatment of invasive cancer, a multidisciplinary clinic has been initiated at the main oncology hospital to streamline care. However, challenges remain such as delays in treatment, lack of trained human personnel, limited follow-up care, and little patient education. Despite improvements in the care of pre-invasive and invasive cervical cancer patients, for declines in cervical cancer-related morbidity and mortality to be achieved, Botswana needs to continue to invest in decreasing the burden of disease and improving patient outcomes of patients with cervical cancer.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 106 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 17%
Student > Bachelor 14 13%
Researcher 12 11%
Other 10 9%
Student > Postgraduate 9 8%
Other 19 18%
Unknown 24 23%
Readers by discipline Count As %
Medicine and Dentistry 39 37%
Social Sciences 9 8%
Nursing and Health Professions 8 8%
Biochemistry, Genetics and Molecular Biology 5 5%
Computer Science 2 2%
Other 10 9%
Unknown 33 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2018.
All research outputs
#16,047,334
of 25,374,647 outputs
Outputs from Frontiers in oncology
#5,632
of 22,416 outputs
Outputs of similar age
#157,787
of 296,420 outputs
Outputs of similar age from Frontiers in oncology
#27
of 78 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,416 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 296,420 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.